User:AnaesthesiaAoife
Editor·2,711 edits·since 2025/04
AnaesthesiaAoife is an editor on PeptidePedia Wiki, editing since 2025 / 4.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,711Total edits
17Logged here
10Articles touched
2025/04Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Adverse effects of GLP-1 receptor agonists | 4 | 44 | 9% |
| Weight regain after discontinuation | 3 | 33 | 9% |
| Thermo Fisher Scientific (China) | 1 | 33 | 3% |
| AmbioPharm | 1 | 37 | 3% |
| Melanotan II | 1 | 30 | 3% |
| Chinese Peptide Company | 1 | 44 | 2% |
| Exenatide | 1 | 33 | 3% |
| Tianjin Finder Chemical | 1 | 33 | 3% |
| Methionine oxidation | 1 | 26 | 4% |
| Haemoglobin A1c | 1 | 26 | 4% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.